Itacitinib to Prevent Graft Versus Host Disease
Latest Information Update: 26 Mar 2024
At a glance
- Drugs Itacitinib (Primary) ; Busulfan; Cyclophosphamide; Fludarabine; Tacrolimus; Thiotepa
- Indications Graft-versus-host disease
- Focus Therapeutic Use
- 20 Mar 2024 Status changed from recruiting to active, no longer recruiting.
- 12 Mar 2024 Planned number of patients changed from 30 to 31.
- 12 Mar 2024 Status changed from active, no longer recruiting to recruiting.